Antipyretic and analgesic methods using optically pure R-ketorolac
US5382591A · kind A · utility
8Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1993 |
| Grant date | Jan 17, 1995 |
| Priority date | — |
| Expiry date | Sep 8, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed utilizing optically pure R-ketorolac for the treatment of pain, including but not limited to pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for example dental pain (e.g., after periodontal surgery) and ophthalmic pain (e.g., after cataract surgery) while avoiding adverse effects which are associated with the administration of the racemic mixture of ketorolac. The optically pure R-ketorolac is also useful in treating pyrexia while avoiding the adverse effects associated with the administration of the racemic mixture of ketorolac.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.